- Home
- DXR vs PYN Comparison
DXR vs PYN Comparison
Compare DXR & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- PYN
- Stock Information
- Founded
- DXR 1970
- PYN 2002
- Country
- DXR United States
- PYN United States
- Employees
- DXR N/A
- PYN N/A
- Industry
- DXR Medical/Dental Instruments
- PYN Investment Managers
- Sector
- DXR Health Care
- PYN Finance
- Exchange
- DXR Nasdaq
- PYN Nasdaq
- Market Cap
- DXR 42.6M
- PYN 34.6M
- IPO Year
- DXR N/A
- PYN N/A
- Fundamental
- Price
- DXR $9.28
- PYN $5.89
- Analyst Decision
- DXR Strong Buy
- PYN
- Analyst Count
- DXR 1
- PYN 0
- Target Price
- DXR $24.75
- PYN N/A
- AVG Volume (30 Days)
- DXR 21.7K
- PYN 19.9K
- Earning Date
- DXR 01-01-0001
- PYN 01-01-0001
- Dividend Yield
- DXR N/A
- PYN 5.07%
- EPS Growth
- DXR N/A
- PYN N/A
- EPS
- DXR 0.35
- PYN N/A
- Revenue
- DXR $154,205.00
- PYN N/A
- Revenue This Year
- DXR N/A
- PYN N/A
- Revenue Next Year
- DXR N/A
- PYN N/A
- P/E Ratio
- DXR $25.91
- PYN N/A
- Revenue Growth
- DXR N/A
- PYN N/A
- 52 Week Low
- DXR $7.11
- PYN $4.84
- 52 Week High
- DXR $10.04
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- DXR 47.02
- PYN 37.79
- Support Level
- DXR $8.76
- PYN $5.94
- Resistance Level
- DXR $9.72
- PYN $6.09
- Average True Range (ATR)
- DXR 0.52
- PYN 0.09
- MACD
- DXR -0.03
- PYN -0.01
- Stochastic Oscillator
- DXR 21.74
- PYN 11.54
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.